Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment.
Despite many learned publications over recent decades, the assessment of active thyroid-associated orbitopathy (TAO) remains difficult and controversial. There are no biochemical, immunological or imaging investigations which can identify active disease reliably, and clinical assessment is still of paramount importance. We therefore review the strengths and weaknesses of all methods of clinical assessment. A new atlas for clinical assessment of soft tissue signs has been developed, and its reproducibility assessed. It details a suggested protocol that could help standardize descriptions of TAO and allow more objective assessment of its activity and severity. This is relevant to general endocrinologists, who have a crucial role in the identification of patients who require ophthalmological assessment. Certain aspects are more relevant to ophthalmologists and endocrinologists who have a special clinical and research interest in TAO. Unless a reproducible system of assessment is devised and widely adopted, it will remain difficult to interpret research meaningfully, particularly if results appear to contradict.
Dickinson
A J
AJ
Department of Ophthalmology, Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK. Jane.Dickinson@ncl.ac.uk
Perros
P
P
D002985:Clinical Protocols; D003229:Conjunctival Diseases / Q000175:diagnosis; D005094:Exophthalmos / Q000175:diagnosis; D005141:Eyelid Diseases / Q000175:diagnosis; D006111:Graves Disease / Q000175:diagnosis*; D006801:Humans; D015835:Ocular Motility Disorders / Q000175:diagnosis; D009901:Optic Nerve Diseases / Q000175:diagnosis; D010781:Photography; D012720:Severity of Illness Index